Gemcitabine 38 mg/mL

Gemcitabine 38 mg/mL is a lyophilized powder for solution, used in intravenous treatments. This single-dose injection is manufactured by Hospira, Inc. and is commonly associated with cancer therapies.

Gemcitabine is primarily used in the treatment of various types of cancer. It works by interfering with the growth and spread of cancer cells. The specific uses of Gemcitabine 38 mg/mL may vary depending on the type and stage of cancer being treated.

Common effects of Gemcitabine may include fatigue, nausea, and a decreased blood cell count. Some individuals may also experience hair loss or changes in appetite. These effects can vary in severity and duration.

Gemcitabine should be handled with care, as it is a potent medication. It is important to follow the instructions provided by a healthcare professional when administering this injection. Proper disposal of used materials is crucial to avoid contamination.

Gemcitabine may interact with other medications, including those that suppress the immune system or affect blood cell production. It is important to inform a healthcare professional about all medications being taken to avoid potential interactions.